A modifiedex vivo skin organ culture system for functional studies

Archives of Dermatological Research

Volumn 293, Issue 4, 2001, Pages 184-190

  Companjen, Arjen R ^a   Van Der Wel, Leontine I ^a   Wei, Liu ^b   Laman, Jon D ^a   Prens, Errol P ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

Cytokine; Dexamethasone; IL 1; LPS; Psoriasis

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; CELL MEMBRANE PROTEIN; CYTOKINE; DEXAMETHASONE; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; CD3 ANTIGEN; CD86 PROTEIN, HUMAN; GAMMA INTERFERON; GLUCOCORTICOID; INTERLEUKIN 1; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LANGERHANS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CULTURE; CYTOLOGY; DRUG EFFECT; FEMALE; IMMUNOLOGY; METABOLISM; METHODOLOGY; ORGAN CULTURE TECHNIQUE; SKIN;

ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD40; ANTIGENS, CD86; CYTOKINES; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; HLA-DR ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; ORGAN CULTURE TECHNIQUES; SKIN;

EID: 0034744451     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030100219     Document Type: Article

References (24)

1. The SCID-hu xenogeneic transplantation model: Complex but telling
2. Induction of psoriasiform inflammation by a bacterial superantigen in the SCID-hu xenogeneic transplantation model
3. Dermal injection of immunocytes induces psoriasis
4. The SCID-hu xenogeneic transplantation model allows screening of anti-psoriatic drugs
5. Skin organ culture: Why?
6. Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8
7. Maintenance of human skin in organ culture: Role for insulin-like growth factor-1 receptor and epidermal growth factor receptor
8. Effects of contact allergens on human Langerhans cells in skin organ culture: Migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein
9. Degradation of newly synthesized high molecular mass hyaluronan in the epidermal and dermal compartments of human skin in organ culture
10. The culture of mature organs in a synthetic medium
11. A simple organ culture method which allows simultaneous isolation of specific types of cells
12. In situ behavior of human Langerhans cells in skin organ culture
13. Detection of inflammatory cytokines in psoriatic skin
14. Human psoriatic skin in organ culture: Comparison with normal skin exposed to exogenous growth factors and effects of an antibody to the EGF receptor
15. LPS-binding proteins and receptors
16. Unresponsiveness of MyD88-deficient mice to endotoxin
17. Characteristics and regulation of the expression on interleukin 1 receptors by murine Langerhans cells and keratinocytes
18. Interleukin-1 receptors type I and type II are differentially regulated in human keratinocytes by ultraviolet B radiation
19. Organ culture of adult human skin; effect of culture temperature
20. Maintenance of epidermal structures of psoriatic skin in organ culture
21. Effect of serum and oxygen tension on human skin organ culture: A histometric analysis
22. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production
23. Direct effects of glucocorticosteroids on epidermal Langerhans cells
24. Expression of interferon-gamma receptors and interferon-gamma-induced up-regulation of intercellular adhesion molecule-1 in basal cell carcinoma; decreased expression of IFN-gamma R and shedding of ICAM-1 as a means to escape immune surveillance